unmet need in hemophilia a: breakthrough bleeds
Published 2 years ago • 132 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
1:36
unmet needs in hemophilia: guidelines for emicizumab & better therapeutics for hemophilia a
-
1:18
unmet needs in hemophilia treatment
-
2:49
insights into areas of unmet need among patients with hemophilia a
-
1:17
the current standard of care in hemophilia and unmet needs in this space
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
6:32
targeted factor viii delivery in hemophilia with inhibitors
-
57:36
laboratory testing for inhibitors in the changing landscape of hemophilia treatment products
-
3:23
new approaches to hemophilia research
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
1:53
unmet needs in amyloidosis: early diagnosis, treating relapsed disease & progression criteria
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:09
low-dose emicizumab prophylaxis in patients with severe hemophilia a
-
2:27
the impact of hemophilia inhibitors on patient outcomes
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b
-
1:35
unmet needs in sickle cell disease
-
1:48
unmet needs in hemoglobinopathy care
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
2:49
haven-6 trial updates: emicizumab in non-severe hemophilia a
-
2:03
unmet needs in immune thrombocytopenia
-
9:36
hemophilia (year of the zebra)
-
2:06
emicizumab prophylaxis in hemophilia a
-
1:06
overview of the diagnostic work-up for hemophilia